Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 36
Filter
1.
J Affect Disord ; 306: 28-31, 2022 06 01.
Article in English | MEDLINE | ID: mdl-35306120

ABSTRACT

BACKGROUND: The economic crisis induced by the COVID-19 pandemic can have a serious impact on population mental health. This study seeks to understand whether the economic shocks associated with the pandemic have a differential impact by sex because the current pandemic may have disproportionally affected women compared to men. METHODS: We analyzed data from original online monthly surveys of the general population in Japan conducted between April 2020 and February 2021 (N = 9000). We investigated whether individuals who had experienced a major job-related adverse change were more likely to have experienced depressive symptoms (PHQ-9) and anxiety disorders (GAD-7) during the pandemic and also if its effect varied by sex. RESULTS: The results of logistic regression suggest that depressive and anxiety symptoms were more prevalent among those who had recently experienced drastic changes in employment and working conditions, as well as among individuals with low income and those without college education. We also found that both female and male respondents who had experienced a major employment-related change exhibited depression and anxiety disorders. LIMITATIONS: We do not have data on the pre-COVID mental health conditions of our respondents, and our findings are descriptive. Some segments of the population may not be represented in our sample because our surveys were conducted online. CONCLUSIONS: COVID-induced economic shocks can have a detrimental effect on mental health among both economically vulnerable female and male workers.


Subject(s)
COVID-19 , Pandemics , Anxiety/epidemiology , COVID-19/epidemiology , Cross-Sectional Studies , Depression/epidemiology , Economic Recession , Female , Humans , Japan/epidemiology , Male , Mental Health , SARS-CoV-2
2.
Biomed Res Int ; 2022: 9770899, 2022.
Article in English | MEDLINE | ID: mdl-35028318

ABSTRACT

Periodontitis is a chronic inflammatory disease caused by periodontopathogenic bacteria that form biofilms in periodontal pockets. The gingival epithelium acts as the first physical barrier in fighting attacks by periodontopathogenic pathogens, such as the primary etiological agent Porphyromonas gingivalis, and various exogenous chemicals, as well as regulates the local innate immune responses. Therefore, the development of novel oral care products to inhibit inflammatory reactions caused by bacterial infection and protect the gingival epithelium is necessary. Juncus effusus L. has generally been used as an indigenous medicine, such as a diuretic, an antipyretic, and an analgesic, in ancient practice. In this study, we examined the effects of a water extract from J. effusus L. on the inhibition of the inflammatory reaction elicited by bacterial infection and protection of the oral epithelium by chemical irritation. Pretreatment of oral epithelial cells with the water extract from J. effusus L. significantly reduced P. gingivalis or its lipopolysaccharide- (LPS-) mediated production of chemokines (interleukin-8 and C-C-chemokine ligand20) in a concentration-dependent manner with comparable to or greater effects than epigallocatechin gallate and protected oral epithelial cells from injury by chemical irritants, cetylpyridinium chloride, and benzethonium chloride. Moreover, the water extract from J. effusus L. in the presence of antimicrobial agents or antifibrinolytics already used as ingredients in mouthwash could significantly reduce the production of chemokines from P. gingivalis LPS-stimulated oral epithelial cells in a concentration-dependent manner. These findings suggest that the water extract from J. effusus L. is potentially useful for oral care to prevent oral infections, such as periodontal infections, and maintain oral epithelial function.


Subject(s)
Anti-Inflammatory Agents , Keratinocytes/metabolism , Magnoliopsida/chemistry , Mouth Mucosa/metabolism , Plant Extracts , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/pharmacology , Bacteroidaceae Infections/metabolism , Bacteroidaceae Infections/prevention & control , Cell Line, Transformed , Humans , Keratinocytes/pathology , Mouth Mucosa/pathology , Periodontitis/metabolism , Periodontitis/pathology , Periodontitis/prevention & control , Plant Extracts/chemistry , Plant Extracts/pharmacology , Porphyromonas gingivalis/metabolism
4.
Adv Healthc Mater ; 3(10): 1555-60, 1524, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24753450

ABSTRACT

Controlled transscleral co-delivery of two drugs, edaravone (EDV) and unoprostone (UNO), using a platform that comprises a microfabricated reservoir, controlled-release cover, and drug formulations, which are made of photopolymerized poly(ethyleneglycol) dimethacrylates, shows synergistic retinal neuroprotection against light injury in rats when compared with single-drug-loaded devices. The device would offer a safer therapeutic method than intravitreal injections for retinal disease treatments.


Subject(s)
Drug Delivery Systems/instrumentation , Drug Delivery Systems/methods , Retina/metabolism , Retinal Diseases/drug therapy , Administration, Ophthalmic , Animals , Antipyrine/administration & dosage , Antipyrine/analogs & derivatives , Antipyrine/pharmacokinetics , Dinoprost/administration & dosage , Dinoprost/analogs & derivatives , Dinoprost/pharmacokinetics , Drug Combinations , Edaravone , Equipment Design , Methacrylates/chemistry , Neuroprotective Agents/administration & dosage , Neuroprotective Agents/pharmacokinetics , Polyethylene Glycols/chemistry , Polymethacrylic Acids/chemistry , Prostheses and Implants , Rats , Retina/radiation effects , Retinal Diseases/etiology , Retinal Diseases/metabolism , Retinal Diseases/prevention & control , Sclera/surgery
5.
Adv Exp Med Biol ; 801: 837-43, 2014.
Article in English | MEDLINE | ID: mdl-24664778

ABSTRACT

We constructed brain-derived neurotrophic factor (BDNF) expressing rat retinal pigment epithelial (RPE) cells by stable transfection of BDNF cDNA, and the RPE cells were cultured on a cross-linked collagen sheet (Coll-RPE-BDNF). BDNF expression of the Coll-RPE-BDNF was confirmed by western blot, and the Coll-RPE-BDNF was transplanted into the rabbit sclera. In vivo BDNF expression was confirmed by His expression that was linked to the expressing BDNF. The effect of the released BDNF was examined in a rabbit acute high intraocular pressure system by electroretinogram and histological examination. Statistically significant preservation of ERG b wave amplitude was observed in the rabbits treated by Coll-RPE-BDNF when compared to that of no treatment. Statistically significant preservation of the thickness of the inner nuclear layer at the transplanted area was observed in the rabbits treated by Coll-RPE-BDNF compared to that of no treatment. Intra-scleral Coll-RPE-BDNF transplantation may partially rescue retinal cells from acute high intraocular pressure.


Subject(s)
Brain-Derived Neurotrophic Factor/metabolism , Cell Transplantation/methods , Intraocular Pressure/physiology , Retina/physiology , Retinal Diseases/surgery , Retinal Pigment Epithelium/transplantation , Animals , Collagen/pharmacology , Cross-Linking Reagents/pharmacology , Electroretinography , Graft Survival , Male , Rabbits , Rats , Retina/cytology , Retinal Diseases/etiology , Retinal Pigment Epithelium/cytology , Retinal Pigment Epithelium/metabolism , Sclera/surgery
6.
Acta Biomater ; 10(2): 680-7, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24239899

ABSTRACT

The design of drug delivery systems that can deliver multiple drugs to the posterior segment of the eye is a challenging task in retinal disease treatments. We report a polymeric device for multi-drug transscleral delivery at independently controlled release rates. The device comprises a microfabricated reservoir, controlled-release cover and three different fluorescent formulations, which were made of photopolymeized tri(ethyleneglycol)dimethacrylate (TEGDM) and poly(ethyleneglycol)dimethacrylate (PEGDM). The release rate of each fluorescent is controlled by varying the PEGDM/TEGDM ratio in its formulation and the cover. The release kinetics appeared to be related to the swelling ratio of the PEGDM/TEGDM polymers. When the devices were implanted onto rat sclerae, fluorescence was observable in the ocular tissues during 4 weeks' implantation and distributed locally around the implantation site. Our polymeric system, which can administer multiple compounds with distinct kinetics, provides prolonged action and less invasive transscleral administration, and is expected to provide new tools for the treatment of posterior eye diseases with new therapeutic modalities.


Subject(s)
Drug Delivery Systems/instrumentation , Methacrylates/chemistry , Polyethylene Glycols/chemistry , Polymethacrylic Acids/chemistry , Posterior Eye Segment/metabolism , Sclera/metabolism , Animals , Diffusion , Fluorescein/metabolism , Indoles/metabolism , Permeability , Prosthesis Implantation , Rats , Retina/metabolism , Rhodamines/metabolism
7.
Retina ; 32(6): 1204-13, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22366904

ABSTRACT

PURPOSE: To determine whether intravitreal vasohibin-1 will reduce the grade of the choroidal neovascularization in monkey eyes. METHODS: Choroidal neovascularizations were induced in 12 monkey eyes by laser photocoagulation. Three monkeys were evaluated for the safety of the vasohibin-1 injections, 6 monkeys for the effects of a single injection, and 3 monkeys for repeated injections of vasohibin-1. Ophthalmoscopy, fluorescein angiography, focal electroretinograms, and optical coherence tomography were used for the evaluations. The level of vascular endothelial growth factor in the aqueous was determined by enzyme-linked immunosorbent assay. Immunohistochemistry was performed. RESULTS: An intravitreal injection of 10 µg of vasohibin-1 induced mild intraocular inflammation. Eyes with an intravitreal injection of 0.1 µg and 1.0 µg of vasohibin-1 had significant less fluorescein leakage from the choroidal neovascularizations and larger amplitude focal electroretinograms than that of vehicle-injected eyes. Similar results were obtained by repeated injections of 0.1 µg of vasohibin-1. Immunohistochemistry showed that vasohibin-1 was expressed mainly in the endothelial cells within the choroidal neovascularizations. The vascular endothelial growth factor level was not significantly altered by intravitreal vasohibin-1. CONCLUSION: The reduction of the laser-induced choroidal neovascularizations and preservation of macular function in monkey by intravitreal vasohibin-1 suggest that it should be considered for suppressing choroidal neovascularizations in humans.


Subject(s)
Angiogenesis Inhibitors/administration & dosage , Cell Cycle Proteins/administration & dosage , Choroidal Neovascularization/drug therapy , Angiogenesis Inhibitors/metabolism , Animals , Cell Cycle Proteins/metabolism , Choroidal Neovascularization/metabolism , Choroidal Neovascularization/pathology , Choroidal Neovascularization/physiopathology , Disease Models, Animal , Electroretinography/drug effects , Enzyme-Linked Immunosorbent Assay , Fluorescein Angiography , Immunohistochemistry , Intravitreal Injections , Macaca , Ophthalmoscopy , Tomography, Optical Coherence , Vascular Endothelial Growth Factor A/metabolism
9.
Invest Ophthalmol Vis Sci ; 52(6): 3272-80, 2011 May 17.
Article in English | MEDLINE | ID: mdl-21345982

ABSTRACT

PURPOSE. To determine the expression of vasohibin-1 during the development of experimentally induced choroidal neovascularization (CNV) and to investigate the effect of vasohibin-1 on the generation of CNV. METHODS. CNV lesions were induced in the eyes of wild-type (WT) and vasohibin-1 knockout (KO) mice by laser photocoagulation. The expression of vasohibin-1, vascular endothelial growth factor (VEGF), VEGF receptor-1 (VEGFR1), VEGFR2, and pigment epithelial-derived factor (PEDF) was determined by semiquantitative reverse transcription-polymerase chain reaction. The expression of vasohibin-1 was also examined by immunohistochemistry with anti-CD68, anti-alpha smooth muscle actin (αSMA), anti-cytokeratin, and anti-CD31. Vasohibin-1 was injected into the vitreous and the activity and size of the CNV were determined by fluorescein angiography and in choroidal flat mounts. RESULTS. Vasohibin-1 was detected not only in CD31-positive endothelial cells but also in CD68-positive macrophages and αSMA-positive retinal pigment epithelial cells. Strong vasohibin-1 expression was observed at day 28, when the CNV lesions had regressed by histologic examination. The vasohibin-1 level was significantly decreased at day 14 and increased at day 28 after laser application. Significantly less VEGFR2 expression was observed on day 4 after vasohibin-1. The expression of PEDF was not significantly changed by vasohibin-1 injection. Vasohibin-1 injection significantly suppressed the CNV, with no adverse side effects. The CNV lesions in the vasohibin-1-KO mice were significantly larger than those in the WT mice. CONCLUSIONS. The endogenous expression of vasohibin-1 is associated with the natural course of the development of CNV. Intravitreal injections of vasohibin-1 may be a method for inhibiting CNV.


Subject(s)
Angiogenesis Inhibitors/pharmacology , Cell Cycle Proteins/genetics , Cell Cycle Proteins/pharmacology , Choroidal Neovascularization/prevention & control , Endothelium, Vascular/metabolism , Actins/metabolism , Animals , Antigens, CD/metabolism , Choroidal Neovascularization/metabolism , Disease Models, Animal , Eye Proteins/genetics , Eye Proteins/metabolism , Fluorescein Angiography , Gene Expression Regulation/physiology , Intravitreal Injections , Keratins/metabolism , Laser Coagulation , Macrophages/metabolism , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Nerve Growth Factors/genetics , Nerve Growth Factors/metabolism , Recombinant Fusion Proteins/pharmacology , Retinal Pigment Epithelium/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Serpins/genetics , Serpins/metabolism , Vascular Endothelial Growth Factor A/genetics , Vascular Endothelial Growth Factor A/metabolism , Vascular Endothelial Growth Factor Receptor-1/genetics , Vascular Endothelial Growth Factor Receptor-1/metabolism , Vascular Endothelial Growth Factor Receptor-2/genetics , Vascular Endothelial Growth Factor Receptor-2/metabolism
10.
J Adhes Dent ; 13(2): 163-9, 2011 Apr.
Article in English | MEDLINE | ID: mdl-20157683

ABSTRACT

PURPOSE: To evaluate the effects of carboxylic and phosphate functional monomers on the bond strength and durability of an acrylic resin joined to a magnetizable stainless steel and its component metals. MATERIALS AND METHODS: Disk specimens (10 and 8 mm in diameter and 2.5 mm thick) were prepared from SUS XM27 stainless steel, high-purity iron, and chromium metals. The specimens were ground with abrasive paper, and divided into an unprimed control group and 4 groups primed with: 1. Alloy Primer (thione and phosphate); 2. Estenia Opaque Primer (phosphate); 3. Mr. Bond (aliphatic carboxylic acid); or 4. Super-Bond C&B Liquid (aromatic carboxylic anhydride). The disks were bonded with tri-n-butylborane (TBB)-initiated resin, and the shear bond strengths were determined both before and after thermocycling (20,000 X, 5°C - 55°C). The debonded surfaces were analyzed using Xray diffraction (XRD). RESULTS: The Alloy Primer and Estenia Opaque Primer materials containing 10-methacryloyloxydecyl dihydrogen phosphate (MDP) effectively bonded the steel (30.3 to 32.4 MPa) and iron (33.6 to 34.8 MPa), whereas the four acidic primers bonded chromium (24.6 to 32.3 MPa). X-ray diffractometry detected corroded iron at the debonded interface. CONCLUSION: Bearing in mind the limitations of the present study, the use of two primers with MDP is recommendable for bonding SUS XM27 steel with TBB-initiated resin. Iron was considered to be a corrosive factor at the adhesive interface, although the associated bonding characteristics were adequate.


Subject(s)
Acrylic Resins , Dental Alloys , Dental Bonding/methods , Resin Cements , Stainless Steel , Acrylic Resins/chemistry , Boron Compounds , Carboxylic Acids , Chromium , Corrosion , Dental Alloys/chemistry , Dental Stress Analysis , Hot Temperature , Iron , Materials Testing , Methacrylates , Methylmethacrylate , Methylmethacrylates , Photoinitiators, Dental , Resin Cements/chemistry , Shear Strength , Stainless Steel/chemistry , Thiones
11.
Biomaterials ; 32(7): 1950-6, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21112628

ABSTRACT

A transscleral drug-delivery device, designed for the administration of protein-type drugs, that consists of a drug reservoir covered with a controlled-release membrane was manufactured and tested. The controlled-release membrane is made of photopolymerized polyethylene glycol dimethacrylate (PEGDM) that contains interconnected collagen microparticles (COLs), which are the routes for drug permeation. The results showed that the release of 40-kDa FITC-dextran (FD40) was dependent on the COL concentration, which indicated that FD40 travelled through the membrane-embedded COLs. Additionally, the sustained-release drug formulations, FD40-loaded COLs and FD40-loaded COLs pelletized with PEGDM, fine-tuned the release of FD40. Capsules filled with COLs that contained recombinant human brain-derived neurotrophic factor (rhBDNF) released bioactive rhBDNF in a manner dependent on the membrane COL concentration, as was found for FD40 release. When capsules were sutured onto sclerae of rabbit eyes, FD40 was found to spread to the retinal pigment epithelium. Implantation of the device was easy, and it did not damage the eye tissues. In conclusion, our capsule is easily modified to accommodate different release rates for protein-type drugs by altering the membrane COL composition and/or drug formulation and can be implanted and removed with minor surgery. The device thus has great potential as a conduit for continuous, controlled drug release.


Subject(s)
Dextrans/metabolism , Drug Delivery Systems/methods , Fluorescein-5-isothiocyanate/analogs & derivatives , Retina/metabolism , Animals , Blotting, Western , Brain-Derived Neurotrophic Factor/metabolism , Collagen/chemistry , Dextrans/administration & dosage , Fluorescein-5-isothiocyanate/administration & dosage , Fluorescein-5-isothiocyanate/metabolism , Humans , Microscopy, Electron, Scanning , Rabbits , Retina/ultrastructure
12.
Ind Health ; 48(6): 758-65, 2010.
Article in English | MEDLINE | ID: mdl-20616458

ABSTRACT

To investigate the effects of sleep hygiene education for workers of an information technology (IT) company, we conducted a controlled clinical trial providing 581 workers one-hour sleep hygiene education. The contents of the sleep hygiene education program were a review of sleep habits, provide sleep hygiene education, and the establishment of sleep habit goals. A self-report questionnaire was used to measure outcomes including the Pittsburgh Sleep Quality Index (PSQI), Karolinska Sleepiness Scale (KSS), Checklist Individual Strength (CIS), Center for Epidemiologic Studies for Depression (CES-D), and mean sleep duration on weekdays before and 4 wk after the intervention. A total of 391 participants were included in the analysis, with 214 participants in the sleep hygiene education group and 177 in the waiting list group. KSS score at 2 P.M. decreased by 0.42 points in the sleep hygiene education group, but increased by 0.08 points in the waiting list group, showing a significant effect size of 0.50 (95%CI, -0.97 to -0.04, p<0.05). PSQI score also improved, but the inter-group difference was not statically significant. The present study provides preliminary evidence that brief sleep hygiene education may improve afternoon sleepiness at work, but not sleep at night for IT workers.


Subject(s)
Depression/diagnosis , Dyssomnias/epidemiology , Health Education , Occupational Health , Wakefulness , Adult , Analysis of Variance , Checklist , Confidence Intervals , Depression/epidemiology , Depression/psychology , Dyssomnias/complications , Dyssomnias/psychology , Female , Health Knowledge, Attitudes, Practice , Health Status Indicators , Humans , Information Systems/statistics & numerical data , Life Style , Male , Psychometrics , Self Report , Surveys and Questionnaires , Time Factors , Tokyo
13.
Adv Exp Med Biol ; 664: 467-71, 2010.
Article in English | MEDLINE | ID: mdl-20238048

ABSTRACT

PURPOSE: p27kip1 is well-known as a cell cycle inhibitor and also plays an important role for cell differentiation. We hypothesized that if we caused retinal degeneration in a p27(-/-) mouse, then the appropriate method of restoration may be different from that of wild mice and therefore suggest a therapeutic methodology for retinal regeneration. METHODS: Histological and electrophysiological (ERG) examination was performed on p27(-/-) mice retina. We injected N-methy-N-nitrosourea (MNU) to induce retinal degeneration. BrdU was used to identify the dividing cells in the retina. RESULTS: Thicker retina were observed in the p27(-/-) mice when compared to those of the p27(-/+) mice or wild type mice. Almost all retinal layers were thick and optic nerves were also enlarged. A statistically significant decrease of a and b waves amplitudes of ERG was observed in p27(-/-) mice when compared to those of the other mice. BrdU and nestin positive cells were present at the outer nuclear layer with no difference between p27(-/-) and wild type mice after MNU injection. CONCLUSION: p27(-/-) mice showed thicker retina and less retinal function than those of other mice. The MNU-induced retinal degeneration in p27(-/-) mice closely resembled the reaction of the other mice with no retinal regeneration observed in our experimental condition.


Subject(s)
Cyclin-Dependent Kinase Inhibitor p27/deficiency , Retinal Degeneration/pathology , Animals , Bromodeoxyuridine/metabolism , Cyclin-Dependent Kinase Inhibitor p27/metabolism , Electroretinography , Fundus Oculi , Immunohistochemistry , Intermediate Filament Proteins/metabolism , Mice , Mice, Knockout , Nerve Tissue Proteins/metabolism , Nestin , Retinal Degeneration/physiopathology
14.
Curr Eye Res ; 34(7): 580-8, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19899971

ABSTRACT

PURPOSE: To determine how brain-derived neurotrophic factor (BDNF) protects photoreceptors against phototoxicity. METHODS: Iris pigment epithelial cells (IPE) that were transduced with different concentrations of adeno-associated virus (AAV) mediated BDNF (AAV-BDNF-IPE) were transplanted into the subretinal space of rats. We also injected small interfering RNAs (siRNAs) for TrkB, a BDNF receptor. The rats were exposed to continuous light to induce phototoxicity. We examined the expression of TrkB in the retina by Western blot and immunohistochemistry. RESULTS: Significant photoreceptor protection was detected when more than 1 x 10(7) capsids/ml AAV-BDNF was transplanted. An intravitreal injection of siRNAs showed that the photoreceptor protection by AAV-BDNF-IPE was reduced by injecting the siRNA of TrkB-T1, one of the TrkB isoforms. TrkB-T1 was slightly upregulated by Western blot, and one of the cells that upregulated TrkB-T1 was Muller cells by immunohistochemistry. CONCLUSION: We conclude that Muller cells are one of the cells responsible for the expression of TrkBs, and TrkB-T1 may play a role in the protection of photoreceptors against phototoxicity.


Subject(s)
Brain-Derived Neurotrophic Factor/physiology , Neuroglia/metabolism , Photoreceptor Cells, Vertebrate/radiation effects , Radiation Injuries, Experimental/prevention & control , Receptor, trkB/physiology , Retinal Degeneration/prevention & control , Animals , Blotting, Western , Cell Transplantation , Dependovirus/genetics , Enzyme-Linked Immunosorbent Assay , Genetic Vectors , Immunohistochemistry , Iris/cytology , Light/adverse effects , Pigment Epithelium of Eye/metabolism , Pigment Epithelium of Eye/transplantation , RNA, Small Interfering/physiology , Radiation Injuries, Experimental/etiology , Rats , Rats, Long-Evans , Rats, Sprague-Dawley , Retinal Degeneration/etiology , Transfection
15.
Rapid Commun Mass Spectrom ; 22(21): 3410-4, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18837070

ABSTRACT

The isotope ratios of ethanol, an important constituent or ingredient of some foods and various beverages and fuels, provide information about biological and geographical origin and quality. We have developed an improved method for measuring the isotope ratio of ethanol in various samples by gas chromatography-high temperature conversion or combustion-isotope ratio mass spectrometry (GC-TC/C-IRMS) with headspace solid-phase microextraction (HS-SPME). A HS-SPME method was developed by optimizing several different parameters, including salt addition, incubation temperature and time, and extraction time. The HS-SPME method enabled us to determine the isotope ratio at low ethanol concentrations (0.08 mM) in 50 min with good precision (+/-0.3 per thousand for delta(13)C and +/-5 per thousand for deltaD). An advantage of this technique is that it can be adapted for use with samples which have high viscosity and contain many matrix compounds, such as alcoholic and non-alcoholic beverages.

16.
Nihon Hotetsu Shika Gakkai Zasshi ; 52(2): 189-93, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18467790

ABSTRACT

PURPOSE: The aim of this study was to assess the effect of acidic primers on adhesive bonding to prefabricated alumina material designed for fixed restorations. METHODS: High-purity alumina disks (Procera AllCeram) were primed with one of the following materials: Acryl Bond, All Bond II Primer B, Alloy Primer, Estenia Opaque Primer, M.L. Primer, MR. Bond, and Super- Bond Liquid. The specimens were bonded with a dualpolymerizing luting composite (Variolink II). Unprimed specimen was prepared as the control. Bond strengths were determined both before and after thermocycling. RESULTS: Average bond strength before thermocycling ranged from 12.0 to 39.1 MPa, whereas average bond strength after thermocycling varied from 0.0 to 26.9 MPa. The statistically highest post-thermocycling bond strength was obtained with the use of the Alloy Primer, Estenia Opaque Primer, and M.L. Primer agents. CONCLUSION: It can be concluded that the use of either the Estenia or Alloy Primer material, which contain 10- methacryloyloxydecyl dihydrogen phosphate (MDP), or the M.L. Primer, which contains 6-methacryloyloxyhexyl phosphonoacetate (6-MHPA), is recommended for bonding the Procera alumina copings with the Variolink II composite.


Subject(s)
Acrylic Resins , Aluminum Oxide , Composite Resins , Dental Bonding , Dental Materials , Materials Testing , Polyurethanes , Methacrylates , Phosphonoacetic Acid
17.
Dent Mater J ; 27(1): 56-60, 2008 Jan.
Article in English | MEDLINE | ID: mdl-18309612

ABSTRACT

This study aimed to evaluate the bonding behaviors of a gold alloy and a titanium-aluminum-niobium (Ti-6Al-7Nb) alloy after priming with three metal conditioners. Cast alloy disks were ground and divided into the following four conditions: (1) unprimed control versus priming with (2) Alloy Primer, (3) Estenia Opaque Primer, or (4) V-Primer. The disks were bonded with tri-n-butylborane (TBB) initiated methacrylic resin, and shear bond strengths were determined both before and after 20,000 times of thermocycling. Alloy Primer and V-Primer--which contained a vinyl-thione monomer--were effective for bonding the Au-Pt-Pd alloy. As for the hydrophobic phosphate monomer contained in Alloy Primer and Estenia Opaque Primer, it was effective for bonding the Ti-6Al-7Nb alloy. Further, when specimens were primed with Alloy Primer that contained both functional monomers, bond strength to Ti-6Al-7Nb alloy was greater than that to Au-Pt-Pd alloy.


Subject(s)
Acrylic Resins/chemistry , Boron Compounds/chemistry , Dental Alloys/chemistry , Dental Bonding , Dental Materials/chemistry , Gold Alloys/chemistry , Methylmethacrylate/chemistry , Phosphates/chemistry , Thiones/chemistry , Titanium/chemistry , Humans , Hydrophobic and Hydrophilic Interactions , Materials Testing , Methacrylates/chemistry , Palladium/chemistry , Platinum/chemistry , Shear Strength , Stress, Mechanical , Temperature , Time Factors , Triazines/chemistry
18.
Am J Vet Res ; 69(3): 343-8, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18312132

ABSTRACT

OBJECTIVE: To clarify regulation of the renin-angiotensin (RA) system in cardiac tissues by measuring angiotensin-converting enzyme (ACE) and chymase activities in cats with pressure-overload cardiac hypertrophy. ANIMALS: 13 adult cats. PROCEDURES: Pressure-overload cardiac hypertrophy was induced by coarctation of the base of the ascending aorta in 6 cats, and 7 cats served as untreated control animals. Cats were examined before and 3 months and 2 years after surgery. Two years after surgery, cardiac hypertrophy was confirmed by echocardiography, and the blood pressure gradient was measured at the site of constriction. Cats were euthanized, and ACE and chymase activities were measured in cardiac tissues. RESULTS: Mean +/- SD pressure gradient across the aortic constriction was 63 +/- 6 mm Hg. Chymase activity predominated (75% to 85%) in the RA system of the cardiac tissues of cats. Fibrosis in the wall of the left ventricle was detected in cats with hypertrophy, and fibrosis of the papillary muscle was particularly evident. CONCLUSIONS AND CLINICAL RELEVANCE: Chronic pressure overload on the heart of cats can activate the RA system in cardiac tissues. A local increase in angiotensin II was one of the factors that sustained myocardial remodeling.


Subject(s)
Cat Diseases/physiopathology , Hypertrophy, Left Ventricular/veterinary , Renin-Angiotensin System/physiology , Animals , Blood Pressure/physiology , Cat Diseases/enzymology , Cat Diseases/pathology , Cats , Chymases/metabolism , Echocardiography/veterinary , Histocytochemistry/veterinary , Hypertrophy, Left Ventricular/enzymology , Hypertrophy, Left Ventricular/pathology , Hypertrophy, Left Ventricular/physiopathology , Peptidyl-Dipeptidase A/metabolism
19.
J Oral Sci ; 49(3): 191-5, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17928724

ABSTRACT

The purpose of this study was to evaluate the effects of functional monomers contained in the primers, as well as alumina particle abrasion on bonding between stainless steel and acrylic resin. SUS XM27 steel was primed with one of the following materials; Alloy Primer, Estenia Opaque Primer, M. L. Primer, and Super-Bond Liquid. Steel disks were either ground flat or alumina-blasted, primed with one of the four agents, and bonded with an acrylic resin (Unifast Trad). Bond strength was determined both before and after thermocycling (2,000 or 20,000 cycles). Among the four priming agents, the Alloy Primer and Estenia Opaque Primer, both of which contain 10-methacryloyloxydecyl dihydrogen phosphate (MDP), exhibited better bonding performance than the others. Alumina air-borne particle abrasion considerably improved the durability of bonding between the steel and the resin material. It can be concluded that alumina blasting followed by priming with an MDP agent is recommended for bonding the resin and SUS XM27 steel.


Subject(s)
Acid Etching, Dental/methods , Air Abrasion, Dental/methods , Dental Alloys , Dental Bonding , Resin Cements , Stainless Steel , Acrylic Resins/chemistry , Aluminum Oxide , Dental Stress Analysis , Denture Retention/instrumentation , Magnetics , Materials Testing , Methylmethacrylates/chemistry , Phase Transition , Resin Cements/chemistry , Shear Strength , Statistics, Nonparametric
20.
J Vet Med Sci ; 69(8): 869-71, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17827900

ABSTRACT

The objective of this study was to evaluate the hemodynamics of the anesthetic isoflurane in healthy cats given angiotensin-converting enzyme inhibitor (ACEI). The 7 healthy young cats and 3 old cats were received placebo or enalapril 0.5 mg/kg orally. The change in systolic arterial pressure from the baseline to 30 min postanesthesia in the ACEI group was significantly higher than in the placebo group (mean +/- SD: -39 +/- 13% vs. -17 +/- 12%, respectively). The present study indicated that general anesthesia may induce hypotension after the administration of an ACEI.


Subject(s)
Anesthesia/veterinary , Anesthetics, Inhalation/pharmacology , Angiotensin-Converting Enzyme Inhibitors/administration & dosage , Angiotensin-Converting Enzyme Inhibitors/pharmacology , Blood Pressure/drug effects , Isoflurane/pharmacology , Anesthesia/adverse effects , Anesthetics, Inhalation/adverse effects , Animals , Cats , Enalapril/administration & dosage , Enalapril/pharmacology , Hypotension/chemically induced , Hypotension/physiopathology , Isoflurane/adverse effects , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...